RaNA Therapeutics, Inc.

13 articles with RaNA Therapeutics, Inc.

• RaNA Therapeutics Relaunches As Translate Bio To Advance RNA Therapeutics

  6/27/2017

• Shire Sells RNA Therapy Program to RaNA Therapeutics for Stake in Company

  1/4/2017

• RaNA Therapeutics Names Thomas McCauley As Chief Scientific Officer

  9/12/2016

• RaNA Therapeutics To Present At Upcoming Conferences

  6/14/2016

• RaNA Therapeutics Awarded First Patent For Transcriptional Activation Platform

  5/3/2016

• RaNA Therapeutics Presents Data On Advances In RNA Therapy Targeting Spinal Muscular Atrophy

  3/23/2016

• RaNA Therapeutics To Present At BIO CEO & Investor Conference And Leerink Partners Global Healthcare Conference

  2/1/2016

• Merck & Co., GlaxoSmithKline and Others Invest $55 Million in RaNA Therapeutics and Its Innovative RNA Technology

  7/23/2015

• RaNA Therapeutics, Inc. To Present At Cowen and Company 35th Annual Healthcare Conference On Monday, March 2nd

  2/26/2015

• RaNA Therapeutics, Inc. To Present At The 2015 Leerink Global Healthcare Conference

  2/5/2015

• RaNA Therapeutics, Inc. Appoints Ronald C. Renaud, Jr., As CEO

  12/1/2014

• RaNA Therapeutics, Inc. and Santaris Pharma A/S Announce Agreement to develop RNA-Targeted Medicines That Selectively Activate Protein Expression

  7/8/2013

• RaNA Therapeutics, Inc. Emerges With $20.7 Million Startup Financing

  1/18/2012